Pridopidine for Huntington’s disease fails to meet the primary endpoint Presented ByProf. Andrew Feigin, NYU Grossman School of Medicine, NY, USA TrialPhase 3, PROOF-HD ConferenceAAN 2023 TypePeer-reviewed article 26 June 2023 20:46